CA2032427A1 — Benzodiazepines analogs
Assigned to Merck and Co Inc · Expires 1991-06-19 · 35y expired
What this patent protects
TITLE OF THE INVENTION NEW BENZODIAZEPINE ANALOGS ABSTRACT OF THE DISCLOSURE Benzodiazepine analogs of the formula: I are disclosed which are antagonists of gastrin and cholecystokinin (CCK) with enhanced aqueous solub…
USPTO Abstract
TITLE OF THE INVENTION NEW BENZODIAZEPINE ANALOGS ABSTRACT OF THE DISCLOSURE Benzodiazepine analogs of the formula: I are disclosed which are antagonists of gastrin and cholecystokinin (CCK) with enhanced aqueous solubility and have properties useful in the treatment of disorders of gastric secretion, appetite regulation, gastrointestinal motility, pancreatic secretion, and dopaminergic function, as well as in treatment producing potentiation of morphine and other opiate analgesics.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.